Kubanda Cryotherapy specializes in a minimally invasive treatment for tumors in pets, offering a novel alternative to traditional surgical methods. Their approach utilizes cryotherapy, which involves applying extreme cold to target and shrink tumors, including lumps and cancers in animals. This technique is designed to provide rapid results with minimal discomfort, as evidenced by testimonials from pet owners and veterinarians who have observed significant improvements in their pets' health shortly after treatment. The procedure is noted for being clean and efficient, eliminating the mess often associated with surgical interventions.

The company is backed by a team of experienced biomedical engineers from Johns Hopkins, emphasizing their commitment to scientific rigor and innovation in veterinary care. Kubanda Cryotherapy is actively involved in clinical research, particularly focusing on the cryotherapy of mammary tumors in dogs. They encourage pet owners to connect with veterinarians to explore this treatment option, highlighting their dedication to improving the quality of life for pets suffering from tumor-related conditions.

United States

We provide the first minimally invasive treatment for benign and malignant masses in pets.
By revolutionizing cryotherapy -- used in human medicine for more than 60 years -- we’re bringing human-quality care to man’s best friends.

Our novel CryoNeedle system uses focused extreme cold to quickly and easily treat tumors, letting pets skip the scalpel and get back to playtime. After six years of successful research and development, including clinical trials at Johns Hopkins Hospital -- we are now launching our treatment offerings to clinics everywhere!

Kubanda Cryotherapy

Company Details